GLUE
Monte Rosa Therapeutics Inc.
Company Overview
| Mkt Cap | $767.67M | Price | $12.85 |
| Volume | 1.15M | Change | -1.23% |
| P/E Ratio | -10.6 | Open | $13.01 |
| Revenue | $75.6M | Prev Close | $13.01 |
| Net Income | $-72.7M | 52W Range | $3.50 - $13.22 |
| Div Yield | N/A | Target | $16.20 |
| Overall | 62 | Value | 60 |
| Quality | 36 | Technical | 91 |
No chart data available
Stock Overview
Updated DailyMonte Rosa Therapeutics Inc. (GLUE) is a leading Professional, Scientific, and Technical Services company in the Research and Development in Biotechnology industry, currently trading at $12.85 with a market capitalization of $767.67 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating concerning quality fundamentals with a MarketXLS quality score of 36.
Today's trading session shows GLUE with a volume of 1.15 million shares. The stock opened down 0.00% from yesterday's close of $13.01. Current analyst estimates project earnings of $-0.3 per share for this year, with next year targeting $-1.08.
GLUE demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for GLUE include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 26.1%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 11:10 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GLUE | $12.85 | -1.2% | 1.15M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Monte Rosa Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW